Lori is the head of insights at BioSpace. She analyzes and comments on industry trends for BioSpace and clients. She creates engaging content for clients to support their marketing objectives. She has been part of an award-winning marketing team and has won a Muse Creative award, a Vega award and several Adobe awards in collaborative team projects for her audio narration work. Her experience in the television/film and audio industries benefits both BioSpace and partners through her moderation and hosting of live and virtual events. While she has covered all elements of the drug development process, her primary focuses are women’s health issues, the economic climate, and the ever-evolving impact of technology – specifically artificial intelligence – on the pharmaceutical industry.

Anne is the co-chair of Crowell & Moring’s Life Sciences and Patents groups, specializing in intellectual property for the biotech and pharma industries. As a first-chair trial lawyer, she employs innovative strategies to represent clients with groundbreaking products, aiming for favorable business resolutions or leveraging litigation for optimal outcomes. Anne excels in navigating complex legal issues, particularly in high-stakes litigations involving life sciences technologies, including cell and gene therapy, often securing key early victories that lead to advantageous settlements. Her expertise includes providing practical advice on patents, unfair competition, and trade secrets, tailored to the unique needs of clients ranging from biotech startups to large pharmaceutical firms. Anne is committed to understanding her clients’ businesses to develop bespoke strategies that align with their risk tolerance and business objectives. Her approach is informed by her deep industry knowledge and dedication to building long-term relationships with in-house counsel. Her focus has included artificial intelligence and its uses in the life sciences industry.

Sahir Ali is an entrepreneur, technology and healthcare leader, investor, and board advisor with extensive experience in Artificial Intelligence, medical imaging, cancer research, enterprise technology, and cloud computing. He has advised and led some of the world’s largest companies and organizations in implementing and integrating cutting-edge technologies and data science practices. He is the founder and general partner of Modi Ventures.

Eli is an advisor and thought partner to life science innovators in biopharma, diagnostics, and medtech, as well as investors active in those areas. He is keenly interested in commercialization, value creation, new product modalities, applications of digital and analytics, and design. Eli has more than two decades of experience in the life sciences, spanning academia, biotech, and consulting.